STEADY-STATE PHARMACOKINETICS OF LOPINAVIR/RITONAVIR IN COMBINATION WITH EFAVIRENZ IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC PATIENTS

The pharmacokinetics of lopinavir/ritonavir (LPV/RTV) 300 mg/m(2) twice daily and efavirenz (EFV) 350 mg/m(2) once daily were evaluated in HIV-infected children. The minimum concentrations for LPV contained values above the target range, and the estimated minimum concentrations for EFV contained val...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: King, Jennifer R., Acosta, Edward P., Yogev, Ram, Wiznia, Andrew, Kraimer, Joyce, Graham, Bobbie, Carey, Vincent, Britto, Paula, Jean-Philippe, Patrick, Moye, John, Watson, Douglas
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2755569/
https://ncbi.nlm.nih.gov/pubmed/19106779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e3181861d8b
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados